Polycystic ovary syndrome (PCOS) disrupts appetite signaling through insulin resistance, altered leptin, and elevated androgens. These imbalances drive cravings and weight gain. Metabolic peptides such as GLP-1 receptor agonists are being studied for their ability to restore appetite control and improve metabolic health in women with PCOS.